SRPT Competitors & Alternatives
Compare Sarepta Therapeutics Inc with similar stocks in the same industry
Biotechnology
SRPT
Main Stock$19.08
Tradestie Score
53
Market Cap
$2.02B
P/E Ratio
55.4
Revenue Growth
0.0%
Analyst Upside
+15.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.16
|
$2.23B | - | 56 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$13.13
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$43.79
|
$2.21B | - | 57 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.52
|
$2.18B | - | 58 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.85
|
$2.08B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.52
|
$2.01B | - | 57 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$34.39
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.32
|
$1.92B | - | 55 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$135.43
|
$1.92B | - | 56 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$57.97
|
$1.90B | 332.9 | 61 | Compare |
More SRPT Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry